BC Week In Review | Sep 15, 2017
Company News

ProQR spins out rare disease play Amylon

ProQR Therapeutics N.V. (NASDAQ:PRQR) spun out CNS-focused Amylon Therapeutics B.V. (Leiden, the Netherlands), which simultaneously raised an undisclosed amount in a seed funding from private and institutional investors. ProQR granted Amylon an exclusive license to...
BC Extra | Sep 13, 2017
Company News

ProQR spins out rare disease play Amylon

ProQR Therapeutics N.V. (NASDAQ:PRQR) spun out CNS-focused Amylon Therapeutics B.V. (Leiden, the Netherlands), which simultaneously raised an undisclosed amount in a seed funding from private and institutional investors. ProQR granted Amylon an exclusive license to...
Items per page:
1 - 2 of 2